{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T17:04:03Z","timestamp":1794071043681,"version":"4.8.0"},"reference-count":89,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T00:00:00Z","timestamp":1684368000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["847949"],"award-info":[{"award-number":["847949"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["FRM EQU202303016287"],"award-info":[{"award-number":["FRM EQU202303016287"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004097","name":"Fondation ARC pour la Recherche sur le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012276","name":"Tillotts Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012276","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-18-CE14-0006-01"],"award-info":[{"award-number":["ANR-18-CE14-0006-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.cgh.2023.04.016","type":"journal-article","created":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T03:49:25Z","timestamp":1682653765000},"page":"2110-2123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Bleeding and Thrombotic Complications in Patients With Cirrhosis: A State-of-the-Art Appraisal"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9567-1859","authenticated-orcid":false,"given":"Pierre-Emmanuel","family":"Rautou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen H.","family":"Caldwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2023.04.016_bib1","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1055\/s-2000-8453","article-title":"Recombinant coagulation factor VIIa: from the concept to clinical application in hemophilia treatment in 2000","volume":"26","author":"Hedner","year":"2000","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.cgh.2023.04.016_bib2","first-page":"1238","article-title":"Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension","volume":"21","author":"Wanless","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2023.04.016_bib3","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/hep.21303","article-title":"Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management","volume":"44","author":"Caldwell","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2023.04.016_bib4","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/hep.20569","article-title":"Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests","volume":"41","author":"Tripodi","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2023.04.016_bib5","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/hep.21266","article-title":"Thrombin generation in patients with cirrhosis: the role of platelets","volume":"44","author":"Tripodi","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2023.04.016_bib6","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1111\/j.1600-6143.2007.01822.x","article-title":"Changes in international normalized ratio (INR) and model for endstage liver disease (MELD) based on selection of clinical laboratory","volume":"7","author":"Trotter","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cgh.2023.04.016_bib7","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/hep.21732","article-title":"The international normalized ratio calibrated for cirrhosis (INR(liver)) normalizes prothrombin time results for model for end-stage liver disease calculation","volume":"46","author":"Tripodi","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2023.04.016_bib8","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/hep.21680","article-title":"A\u00a0modified international normalized ratio as an effective way of prothrombin time standardization in hepatology","volume":"46","author":"Bellest","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2023.04.016_bib9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.21231","article-title":"Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity","volume":"44","author":"Lisman","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2023.04.016_bib10","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1055\/s-0040-1715102","article-title":"Thrombin generation and cirrhosis: state of the art and perspectives","volume":"46","author":"Lebreton","year":"2020","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.cgh.2023.04.016_bib11","article-title":"Gut dysbiosis, endotoxemia and clotting activation: a dangerous trio for portal vein thrombosis in cirrhosis","volume":"57","author":"Violi","year":"2022","journal-title":"Blood Rev"},{"key":"10.1016\/j.cgh.2023.04.016_bib12","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1111\/j.1572-0241.2006.00588.x","article-title":"Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism","volume":"101","author":"Northup","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2023.04.016_bib13","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1053\/j.gastro.2019.01.265","article-title":"Diagnosis, development, and treatment of portal vein thrombosis in patients with and without cirrhosis","volume":"156","author":"Intagliata","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2023.04.016_bib14","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.jhep.2021.11.004","article-title":"Haemostatic alterations and management of haemostasis in patients with cirrhosis","volume":"76","author":"Lisman","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2023.04.016_bib15","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1111\/liv.14404","article-title":"The impact of ABO blood type on the prevalence of portal vein thrombosis in patients with advanced chronic liver disease","volume":"40","author":"Scheiner","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2023.04.016_bib16","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jhep.2021.12.038","article-title":"Factor VIII\/protein C ratio independently predicts liver-related events but does not indicate a hypercoagulable state in ACLD","volume":"76","author":"Scheiner","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2023.04.016_bib17","doi-asserted-by":"crossref","first-page":"231","DOI":"10.5114\/ceh.2021.107566","article-title":"CD62P (P-selectin) expression as a platelet activation marker in patients with liver cirrhosis with and without cholestasis","volume":"7","author":"Hegazy","year":"2021","journal-title":"Clin Exp Hepatol"},{"key":"10.1016\/j.cgh.2023.04.016_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-97233-3","article-title":"Neutrophil extracellular traps in patients with liver cirrhosis and hepatocellular carcinoma","volume":"11","author":"Zenlander","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.cgh.2023.04.016_bib19","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1111\/j.1478-3231.2011.02617.x","article-title":"NADPH oxidase-mediated platelet isoprostane over-production in cirrhotic patients: implication for platelet activation","volume":"31","author":"Basili","year":"2011","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2023.04.016_bib20","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1053\/j.gastro.2012.07.018","article-title":"Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis","volume":"143","author":"Villa","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2023.04.016_bib21","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1159\/000330292","article-title":"The white nipple sign: please do not disturb","volume":"5","author":"Khan","year":"2011","journal-title":"Case Rep Gastroenterol"},{"key":"10.1016\/j.cgh.2023.04.016_bib22","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1111\/j.1538-7836.2012.04901.x","article-title":"Evidence for an enhanced fibrinolytic capacity in cirrhosis as measured with two different global fibrinolysis tests","volume":"10","author":"Rijken","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.cgh.2023.04.016_bib23","doi-asserted-by":"crossref","first-page":"205","DOI":"10.5604\/01.3001.0010.8635","article-title":"Viscoelastic testing in liver disease","volume":"17","author":"Davis","year":"2018","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.cgh.2023.04.016_bib24","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0168-8278(02)00208-8","article-title":"Bacterial infection in cirrhosis impairs coagulation by a heparin effect: a prospective study","volume":"37","author":"Montalto","year":"2002","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2023.04.016_bib25","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/liv.15132","article-title":"Fibrin clot quality in acutely ill cirrhosis patients: Relation with outcome and improvement with coagulation factor concentrates","volume":"42","author":"Blasi","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2023.04.016_bib26","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3390\/antiox9080737","article-title":"Super-resolution microscopy reveals an altered fibrin network in cirrhosis: the key role of oxidative stress in fibrinogen structural modifications","volume":"9","author":"Becatti","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.cgh.2023.04.016_bib27","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1055\/a-1515-9529","article-title":"Intraperitoneal activation of coagulation and fibrinolysis in patients with cirrhosis and ascites","volume":"122","author":"Thaler","year":"2022","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cgh.2023.04.016_bib28","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.dld.2019.03.011","article-title":"Acute kidney injury is associated with low factor XIII in decompensated cirrhosis","volume":"51","author":"Intagliata","year":"2019","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2023.04.016_bib29","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/hep.510290437","article-title":"Infection and hemostasis in decompensated cirrhosis: a prospective study using thrombelastography","volume":"29","author":"Papatheodoridis","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2023.04.016_bib30","article-title":"Global hemostatic profiling in patients with decompensated cirrhosis and bacterial infections","volume":"4","author":"Zanetto","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1016\/j.cgh.2023.04.016_bib31","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/jth.14330","article-title":"Chronic liver injury drives non-traditional intrahepatic fibrin(ogen) crosslinking via tissue transglutaminase","volume":"17","author":"Poole","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.cgh.2023.04.016_bib32","article-title":"Step up to the platelet: role of platelets in inflammation and infection","author":"Carestia","year":"2022","journal-title":"Thromb Res"},{"key":"10.1016\/j.cgh.2023.04.016_bib33","author":"Intagliata","year":"2023","journal-title":"Procedural related bleeding in hospitalized patients with liver disease (PROC-BLeeD): an international, prospective, multicenter observational study"},{"key":"10.1016\/j.cgh.2023.04.016_bib34","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1111\/liv.13712","article-title":"Acute kidney injury, but not sepsis, is associated with higher procedure-related bleeding in patients with decompensated cirrhosis","volume":"38","author":"Hung","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2023.04.016_bib35","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1002\/hep.31443","article-title":"Acute kidney injury in decompensated cirrhosis is associated with both hypo-coagulable and hyper-coagulable features","volume":"72","author":"Zanetto","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2023.04.016_bib36","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/jth.15562","article-title":"Periprocedural management of abnormal coagulation parameters and thrombocytopenia in patients with cirrhosis: guidance from the SSC of the ISTH","volume":"20","author":"Roberts","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.cgh.2023.04.016_bib37","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.jhep.2021.09.003","article-title":"EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis","volume":"76","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2023.04.016_bib38","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/hep.31646","article-title":"Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases","volume":"73","author":"Northup","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2023.04.016_bib39","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1053\/j.gastro.2021.09.004","article-title":"AGA technical review on coagulation in cirrhosis","volume":"161","author":"Intagliata","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2023.04.016_bib40","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/apt.16078","article-title":"Systematic review with meta-analysis: abnormalities in the international normalised ratio do not correlate with periprocedural bleeding events among patients with cirrhosis","volume":"52","author":"Kovalic","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2023.04.016_bib41","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13508","article-title":"Procedure-related bleeding risk in patients with cirrhosis and severe thrombocytopenia","volume":"51","author":"Alvaro","year":"2021","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.cgh.2023.04.016_bib42","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/hep.28628","article-title":"Coagulation parameters and major bleeding in critically ill patients with cirrhosis","volume":"64","author":"Drolz","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2023.04.016_bib43","doi-asserted-by":"crossref","first-page":"830","DOI":"10.5604\/01.3001.0012.0775","article-title":"Low fibrinogen levels are associated with bleeding after varices ligation in thrombocytopenic cirrhotic patients","volume":"17","author":"Giannini","year":"2018","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.cgh.2023.04.016_bib44","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1007\/s10620-019-05939-2","article-title":"A\u00a0randomized control trial of thromboelastography-guided transfusion in cirrhosis for high-risk invasive liver-related procedures","volume":"65","author":"Vuyyuru","year":"2020","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2023.04.016_bib45","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/hep.28148","article-title":"Thrombelastography-guided blood product use before invasive procedures in cirrhosis with severe coagulopathy: a randomized, controlled trial","volume":"63","author":"De Pietri","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2023.04.016_bib46","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1016\/j.transproceed.2010.05.144","article-title":"Thromboelastography-guided transfusion decreases intraoperative blood transfusion during orthotopic liver transplantation: randomized clinical trial","volume":"42","author":"Wang","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1016\/j.cgh.2023.04.016_bib47","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/vox.13225","article-title":"Viscoelastometric versus standard coagulation tests to guide periprocedural transfusion in adults with cirrhosis: a meta-analysis of randomized controlled trials","volume":"117","author":"Tangcheewinsirikul","year":"2022","journal-title":"Vox Sang"},{"key":"10.1016\/j.cgh.2023.04.016_bib48","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/EJA.0000000000001084","article-title":"The use of a thromboelastometry-based algorithm reduces the need for blood product transfusion during orthotopic liver transplantation: a randomised controlled study","volume":"36","author":"Bonnet","year":"2019","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.cgh.2023.04.016_bib49","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1111\/jth.15888","article-title":"Predicting bleeding after liver biopsy using comprehensive clinical and laboratory investigations: a prospective analysis of 302 procedures","volume":"20","author":"Bissonnette","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.cgh.2023.04.016_bib79","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1136\/gutjnl-2020-321299","article-title":"Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology","volume":"69","author":"Neuberger","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2023.04.016_bib80","doi-asserted-by":"crossref","first-page":"18","DOI":"10.14309\/ajg.0000000000000486","article-title":"ACG Clinical Guideline: disorders of the hepatic and mesenteric circulation","volume":"115","author":"Simonetto","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2023.04.016_bib81","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1053\/j.gastro.2021.08.015","article-title":"AGA Clinical Practice Guideline on the management of coagulation disorders in\u00a0patients with cirrhosis","volume":"161","author":"O'Shea","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2023.04.016_bib50","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/S0140-6736(20)30848-5","article-title":"Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial","volume":"395","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2023.04.016_bib51","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1007\/s12072-021-10247-x","article-title":"A\u00a0network meta-analysis of direct oral anticoagulants for portal vein thrombosis in cirrhosis","volume":"15","author":"Ng","year":"2021","journal-title":"Hepatol Int"},{"key":"10.1016\/j.cgh.2023.04.016_bib52","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1002\/hep.32019","article-title":"Risk and outcome of venous and arterial thrombosis in patients with cirrhosis: a Danish nation-wide cohort study","volume":"74","author":"Jepsen","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2023.04.016_bib53","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.cgh.2010.05.014","article-title":"Liver cirrhosis is associated with venous thromboembolism among hospitalized patients in a nationwide US study","volume":"8","author":"Wu","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.04.016_bib54","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejim.2022.05.032","article-title":"Epidemiology of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis","volume":"104","author":"Pan","year":"2022","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.cgh.2023.04.016_bib55","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.27546","article-title":"Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal study","volume":"61","author":"Nery","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2023.04.016_bib56","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/ajg.2012.452","article-title":"De novo portal vein thrombosis in virus-related cirrhosis: predictive factors and long-term outcomes","volume":"108","author":"Maruyama","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2023.04.016_bib82","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.thromres.2013.08.001","article-title":"Efficacy and safety of the use of heparin as thromboprophylaxis in patients with liver cirrhosis: a systematic review and meta-analysis","volume":"132","author":"Gomez Cuervo","year":"2013","journal-title":"Thromb Res"},{"key":"10.1016\/j.cgh.2023.04.016_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2023.02.023","article-title":"Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: the IMPORTAL competing-risk meta-analysis","author":"Guerrero","year":"2023","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2023.04.016_bib70","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.dld.2021.07.039","article-title":"Efficacy and safety of direct oral anticoagulants versus vitamin K antagonist for portal vein thrombosis in cirrhosis: a systematic review and meta-analysis","volume":"54","author":"Koh","year":"2022","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2023.04.016_bib83","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8859602","article-title":"Safety and efficacy of anticoagulation in patients with cirrhosis: a meta-analysis","volume":"2021","author":"Chen","year":"2021","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.04.016_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2021.101649","article-title":"Efficacy and safety of anticoagulants in liver cirrhosis patients with portal vein thrombosis: a meta-analysis","volume":"45","author":"Gao","year":"2021","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.cgh.2023.04.016_bib85","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s12325-020-01550-4","article-title":"Anticoagulation favors thrombus recanalization and survival in patients with liver cirrhosis and portal vein thrombosis: results of a meta-analysis","volume":"38","author":"Wang","year":"2021","journal-title":"Adv Ther"},{"key":"10.1016\/j.cgh.2023.04.016_bib69","first-page":"521","article-title":"Treatment response and bleeding events associated with anticoagulant therapy of portal vein thrombosis in cirrhotic patients: systematic review and meta-analysis","volume":"33","author":"Mohan","year":"2020","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.cgh.2023.04.016_bib86","first-page":"104","article-title":"Efficacy and safety of anticoagulation in non-malignant portal vein thrombosis in patients with liver cirrhosis: a systematic review and meta-analysis","volume":"34","author":"Ghazaleh","year":"2021","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.cgh.2023.04.016_bib72","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1053\/j.gastro.2017.04.042","article-title":"Effects of anticoagulants in patients with cirrhosis and portal vein thrombosis: a systematic review and meta-analysis","volume":"153","author":"Loffredo","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2023.04.016_bib87","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.12998\/wjcc.v9.i19.5179","article-title":"Systematic review and meta-analysis of trans-jugular intrahepatic portosystemic shunt for cirrhotic patients with portal vein thrombosis","volume":"9","author":"Zhang","year":"2021","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.cgh.2023.04.016_bib88","doi-asserted-by":"crossref","DOI":"10.1177\/1076029619888026","article-title":"Anticoagulation and transjugular intrahepatic portosystemic shunting for treatment of portal vein thrombosis in cirrhosis: a systematic review and meta-analysis","volume":"25","author":"Davis","year":"2019","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.cgh.2023.04.016_bib77","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/apt.15044","article-title":"Systematic review with meta-analysis: portal vein recanalisation and transjugular intrahepatic portosystemic shunt for portal vein thrombosis","volume":"49","author":"Rodrigues","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2023.04.016_bib78","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1097\/MEG.0000000000001219","article-title":"The role of transjugular intrahepatic portosystemic shunt in the management of portal vein thrombosis: a systematic review and meta-analysis","volume":"30","author":"Valentin","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.04.016_bib89","doi-asserted-by":"crossref","first-page":"4516","DOI":"10.1182\/bloodadvances.2022007961","article-title":"Anticoagulant therapy for splanchnic vein thrombosis: an individual patient data meta-analysis","volume":"6","author":"Candeloro","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.cgh.2023.04.016_bib67","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1055\/s-0040-1722192","article-title":"Anticoagulant treatment for splanchnic vein thrombosis in liver cirrhosis: a systematic review and meta-analysis","volume":"121","author":"Valeriani","year":"2021","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cgh.2023.04.016_bib57","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/0897190015611570","article-title":"A\u00a0retrospective cohort analysis of pharmacologic VTE prophylaxis and padua prediction score in hospitalized patients with chronic liver disease","volume":"30","author":"Moorehead","year":"2017","journal-title":"J\u00a0Pharm Pract"},{"key":"10.1016\/j.cgh.2023.04.016_bib58","doi-asserted-by":"crossref","first-page":"658","DOI":"10.2146\/ajhp110402","article-title":"Pharmacologic prophylaxis against venous thromboembolism in hospitalized patients with cirrhosis and associated coagulopathies","volume":"69","author":"Koliscak","year":"2012","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.cgh.2023.04.016_bib59","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.thromres.2014.09.031","article-title":"Risk-assessment and pharmacological prophylaxis of venous thromboembolism in hospitalized patients with chronic liver disease","volume":"134","author":"Bogari","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.cgh.2023.04.016_bib60","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/jth.13000","article-title":"Safety and efficacy of pharmacological thromboprophylaxis for hospitalized patients with cirrhosis: a single-center retrospective cohort study","volume":"13","author":"Shatzel","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.cgh.2023.04.016_bib61","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1007\/s10620-015-4012-2","article-title":"Direct oral anticoagulants in cirrhosis patients pose similar risks of bleeding when compared to traditional anticoagulation","volume":"61","author":"Intagliata","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2023.04.016_bib62","doi-asserted-by":"crossref","first-page":"67","DOI":"10.14740\/gr1493","article-title":"The incidence of venous thromboembolism and practice of deep venous thrombosis prophylaxis among hospitalized cirrhotic patients","volume":"15","author":"Alsheikh","year":"2022","journal-title":"Gastroenterology Res"},{"key":"10.1016\/j.cgh.2023.04.016_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104825","article-title":"What intervention regimen is most effective prevention for Portal venous system thrombosis after splenectomy in cirrhotics patients with Portal hypertension? Systematic review and network meta-analysis","volume":"157","author":"Ding","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.cgh.2023.04.016_bib64","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII - renewing consensus in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2023.04.016_bib65","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.thromres.2018.08.011","article-title":"Direct oral anticoagulants in patients with liver cirrhosis: a systematic review","volume":"170","author":"Hoolwerf","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.cgh.2023.04.016_bib66","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1111\/jth.15829","article-title":"Thromboprophylaxis for venous thromboembolism prevention in hospitalized patients with cirrhosis: guidance from the\u00a0SSC of the ISTH","volume":"20","author":"Roberts","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.cgh.2023.04.016_bib68","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1007\/s12072-021-10233-3","article-title":"A\u00a0systematic review and meta-analysis of anticoagulation therapy for portal vein thrombosis in patients with cirrhosis: to treat or not to treat?","volume":"15","author":"Dong","year":"2021","journal-title":"Hepatol Int"},{"key":"10.1016\/j.cgh.2023.04.016_bib71","doi-asserted-by":"crossref","DOI":"10.1177\/10760296221104797","article-title":"The efficacy and safety of anticoagulants in the treatment of cirrhotic portal vein thrombosis: a systematic review and meta-analysis","volume":"28","author":"Zhang","year":"2022","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.cgh.2023.04.016_bib73","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.cgh.2017.10.016","article-title":"Harmful and beneficial effects of anticoagulants in patients with cirrhosis and portal\u00a0vein thrombosis","volume":"16","author":"La Mura","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2023.04.016_bib75","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200104","article-title":"Rivaroxaban prophylaxis in noncirrhotic portal vein thrombosis","volume":"1","author":"Plessier","year":"2022","journal-title":"NEJM Evid"},{"key":"10.1016\/j.cgh.2023.04.016_bib76","article-title":"Management of splanchnic vein thrombosis","volume":"5","author":"Elkrief","year":"2023","journal-title":"JHEP Rep"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356523003166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356523003166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:42:30Z","timestamp":1761543750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356523003166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":89,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S1542356523003166"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2023.04.016","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bleeding and Thrombotic Complications in Patients With Cirrhosis: A State-of-the-Art Appraisal","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2023.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}]}}